$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 13 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 50.97 | 509 | 25,945 | 335,916 | 336.4 K to 335.9 K (-0.15 %) |
Jun 13 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 50.14 | 4,991 | 250,254 | 336,425 | 341.4 K to 336.4 K (-1.46 %) |
Jun 13 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.33 | 5,500 | 95,315 | 341,416 | 335.9 K to 341.4 K (+1.64 %) |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 51.72 | 20,000 | 1,034,400 | 20,000 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.48 | 13,500 | 370,980 | 40,580 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 27.00 | 20,000 | 540,000 | 41,700 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 28.05 | 16,268 | 456,317 | 3,732 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 29.34 | 12,000 | 352,080 | 0 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 22.98 | 9,000 | 206,820 | 0 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.18 | 10,000 | 171,800 | 0 | |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 43.54 | 4,052 | 176,432 | 17,009 | 21.1 K to 17 K (-19.24 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 43.42 | 8,594 | 373,159 | 21,061 | 29.7 K to 21.1 K (-28.98 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 43.41 | 10,000 | 434,088 | 29,655 | 39.7 K to 29.7 K (-25.22 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.18 | 10,000 | 171,800 | 39,655 | 29.7 K to 39.7 K (+33.72 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 48.57 | 12,000 | 582,883 | 29,655 | 41.7 K to 29.7 K (-28.81 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 29.34 | 12,000 | 352,080 | 41,655 | 29.7 K to 41.7 K (+40.47 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 48.33 | 6,629 | 320,370 | 29,655 | 36.3 K to 29.7 K (-18.27 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 47.57 | 9,639 | 458,569 | 36,284 | 45.9 K to 36.3 K (-20.99 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 28.05 | 16,268 | 456,317 | 45,923 | 29.7 K to 45.9 K (+54.86 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 46.83 | 12,448 | 582,891 | 29,655 | 42.1 K to 29.7 K (-29.57 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 46.07 | 7,552 | 347,884 | 42,103 | 49.7 K to 42.1 K (-15.21 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 20,000 | 540,000 | 49,655 | 29.7 K to 49.7 K (+67.44 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 45.47 | 2,523 | 114,718 | 29,655 | 32.2 K to 29.7 K (-7.84 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 44.67 | 10,977 | 490,333 | 32,178 | 43.2 K to 32.2 K (-25.44 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.48 | 13,500 | 370,980 | 43,155 | 29.7 K to 43.2 K (+45.52 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 43.87 | 9,000 | 394,837 | 29,655 | 38.7 K to 29.7 K (-23.28 %) |
Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 22.98 | 9,000 | 206,820 | 38,655 | 29.7 K to 38.7 K (+30.35 %) |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Payment of Exercise | F | 38.00 | 1,153 | 43,814 | 37,667 | 38.8 K to 37.7 K (-2.97 %) |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 67,900 | |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 72,900 | |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 38.09 | 5,000 | 190,457 | 236,157 | 241.2 K to 236.2 K (-2.07 %) |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 38.08 | 5,000 | 190,421 | 241,157 | 246.2 K to 241.2 K (-2.03 %) |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 5,000 | 85,900 | 246,157 | 241.2 K to 246.2 K (+2.07 %) |
May 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 5,000 | 85,900 | 241,157 | 236.2 K to 241.2 K (+2.12 %) |
May 11 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.33 | 5,500 | 95,315 | 34,500 | |
May 11 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 37.25 | 2,575 | 95,931 | 335,916 | 338.5 K to 335.9 K (-0.76 %) |
May 11 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 36.11 | 2,925 | 105,612 | 338,491 | 341.4 K to 338.5 K (-0.86 %) |
May 11 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.33 | 5,500 | 95,315 | 341,416 | 335.9 K to 341.4 K (+1.64 %) |
May 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.50 | 1,497 | 48,653 | 29,655 | 31.2 K to 29.7 K (-4.81 %) |
Apr 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 15,000 | 257,700 | 77,900 | |
Apr 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 33.19 | 15,000 | 497,880 | 236,157 | 251.2 K to 236.2 K (-5.97 %) |
Apr 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 15,000 | 257,700 | 251,157 | 236.2 K to 251.2 K (+6.35 %) |
Apr 03 2018 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 31.29 | 319 | 9,982 | 5,837 | 5.5 K to 5.8 K (+5.78 %) |
Apr 03 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 31.29 | 319 | 9,982 | 67,124 | 66.8 K to 67.1 K (+0.48 %) |
Apr 03 2018 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 31.29 | 319 | 9,982 | 10,058 | 9.7 K to 10.1 K (+3.28 %) |
Mar 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 92,900 | |
Mar 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 32.01 | 5,000 | 160,048 | 236,157 | 241.2 K to 236.2 K (-2.07 %) |
Mar 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 5,000 | 85,900 | 241,157 | 236.2 K to 241.2 K (+2.12 %) |
Mar 16 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,155 | 0 | 236,157 | 237.3 K to 236.2 K (-0.49 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 300 | 5,199 | 0 | |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 300 | 5,199 | 0 | |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 4,700 | 81,451 | 300 | |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 4,700 | 81,451 | 300 | |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 33.47 | 300 | 10,042 | 44,754 | 45.1 K to 44.8 K (-0.67 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 33.47 | 300 | 10,042 | 44,754 | 45.1 K to 44.8 K (-0.67 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 32.76 | 4,700 | 153,972 | 45,054 | 49.8 K to 45.1 K (-9.45 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 32.76 | 4,700 | 153,972 | 45,054 | 49.8 K to 45.1 K (-9.45 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 300 | 5,199 | 49,754 | 49.5 K to 49.8 K (+0.61 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 300 | 5,199 | 49,754 | 49.5 K to 49.8 K (+0.61 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 4,700 | 81,451 | 49,454 | 44.8 K to 49.5 K (+10.50 %) |
Mar 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 4,700 | 81,451 | 49,454 | 44.8 K to 49.5 K (+10.50 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 338,947 | 330.7 K to 338.9 K (+2.49 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 11,369,282 | 11.4 M to 11.4 M (+0.07 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 1,778,613 | 1.8 M to 1.8 M (+0.47 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 52,339 | 44.1 K to 52.3 K (+18.71 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 212,998 | 204.7 K to 213 K (+4.03 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 233,262 | 225 K to 233.3 K (+3.67 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 33.38 | 200 | 6,676 | 16,531 | 16.7 K to 16.5 K (-1.20 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 32.89 | 3,174 | 104,404 | 16,731 | 19.9 K to 16.7 K (-15.95 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Sell | S | 33.35 | 300 | 10,005 | 21,387 | 21.7 K to 21.4 K (-1.38 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Sell | S | 32.81 | 4,642 | 152,285 | 21,687 | 26.3 K to 21.7 K (-17.63 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 200 | 3,466 | 5,000 | |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 4,800 | 83,184 | 5,200 | |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 33.37 | 200 | 6,674 | 44,754 | 45 K to 44.8 K (-0.44 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 32.88 | 4,800 | 157,800 | 44,954 | 49.8 K to 45 K (-9.65 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 200 | 3,466 | 49,754 | 49.6 K to 49.8 K (+0.40 %) |
Feb 22 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 4,800 | 83,184 | 49,554 | 44.8 K to 49.6 K (+10.73 %) |
Feb 20 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Payment of Exercise | F | 32.66 | 6,232 | 203,537 | 59,617 | 65.8 K to 59.6 K (-9.46 %) |
Feb 15 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 10,000 | 171,800 | 97,900 | |
Feb 15 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 32.93 | 10,000 | 329,336 | 65,849 | 75.8 K to 65.8 K (-13.18 %) |
Feb 15 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 10,000 | 171,800 | 75,849 | 65.8 K to 75.8 K (+15.19 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Option Exercise | A | 33.21 | 34,640 | 1,150,394 | 34,640 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Grant | A | 0.00 | 15,060 | 0 | 40,885 | 25.8 K to 40.9 K (+58.32 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | A | 33.21 | 17,420 | 578,518 | 17,420 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Grant | A | 0.00 | 7,570 | 0 | 35,948 | 28.4 K to 35.9 K (+26.68 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | A | 33.21 | 14,150 | 469,922 | 14,150 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Grant | A | 0.00 | 6,150 | 0 | 21,904 | 15.8 K to 21.9 K (+39.04 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Option Exercise | A | 33.21 | 26,060 | 865,453 | 26,060 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Grant | A | 0.00 | 11,330 | 0 | 29,130 | 17.8 K to 29.1 K (+63.65 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 33.21 | 46,810 | 1,554,560 | 46,810 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 6,790 | 0 | 34,267 | 27.5 K to 34.3 K (+24.71 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | A | 33.21 | 41,570 | 1,380,540 | 41,570 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Grant | A | 0.00 | 6,030 | 0 | 338,741 | 332.7 K to 338.7 K (+1.81 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Pla Frederic | Chief Bus & Prod De ... | Option Exercise | A | 33.21 | 67,530 | 2,242,671 | 67,530 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Pla Frederic | Chief Bus & Prod De ... | Grant | A | 0.00 | 9,790 | 0 | 42,312 | 32.5 K to 42.3 K (+30.10 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | A | 33.21 | 52,330 | 1,737,879 | 52,330 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Grant | A | 0.00 | 7,590 | 0 | 47,936 | 40.3 K to 47.9 K (+18.81 %) |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 33.21 | 165,100 | 5,482,971 | 165,100 | |
Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 23,930 | 0 | 65,849 | 41.9 K to 65.8 K (+57.09 %) |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 200 | 3,436 | 107,900 | |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 9,800 | 168,364 | 108,100 | |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 35.70 | 200 | 7,140 | 41,919 | 42.1 K to 41.9 K (-0.47 %) |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 200 | 3,436 | 42,119 | 41.9 K to 42.1 K (+0.48 %) |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 34.97 | 9,800 | 342,745 | 41,919 | 51.7 K to 41.9 K (-18.95 %) |
Jan 18 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 9,800 | 168,364 | 51,719 | 41.9 K to 51.7 K (+23.38 %) |
Jan 10 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 5,000 | 86,650 | 10,000 | |
Jan 10 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 35.51 | 5,000 | 177,566 | 40,346 | 45.3 K to 40.3 K (-11.03 %) |
Jan 10 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 5,000 | 86,650 | 45,346 | 40.3 K to 45.3 K (+12.39 %) |
Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 2,169 | 37,589 | 0 | |
Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 34.09 | 835 | 28,465 | 27,477 | 28.3 K to 27.5 K (-2.95 %) |
Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 34.09 | 2,169 | 73,941 | 28,312 | 30.5 K to 28.3 K (-7.12 %) |
Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 2,169 | 37,589 | 30,481 | 28.3 K to 30.5 K (+7.66 %) |
Dec 20 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Option Exercise | M | 27.00 | 5,000 | 135,000 | 9,710 | |
Dec 20 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Sell | S | 36.82 | 334 | 12,298 | 17,800 | 18.1 K to 17.8 K (-1.84 %) |
Dec 20 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Sell | S | 37.00 | 5,000 | 185,000 | 18,134 | 23.1 K to 18.1 K (-21.61 %) |
Dec 20 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Buy | M | 27.00 | 5,000 | 135,000 | 23,134 | 18.1 K to 23.1 K (+27.57 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 17.33 | 9,000 | 155,970 | 0 | |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 21.52 | 12,000 | 258,240 | 0 | |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 35.00 | 9,000 | 315,000 | 15,754 | 24.8 K to 15.8 K (-36.36 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 17.33 | 9,000 | 155,970 | 24,754 | 15.8 K to 24.8 K (+57.13 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 32.00 | 12,000 | 384,000 | 15,754 | 27.8 K to 15.8 K (-43.24 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 21.52 | 12,000 | 258,240 | 27,754 | 15.8 K to 27.8 K (+76.17 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.18 | 7,100 | 121,978 | 117,900 | |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 17.33 | 12,900 | 223,557 | 0 | |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 33.00 | 10,000 | 330,000 | 41,919 | 51.9 K to 41.9 K (-19.26 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 30.00 | 10,000 | 300,000 | 51,919 | 61.9 K to 51.9 K (-16.15 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.18 | 7,100 | 121,978 | 61,919 | 54.8 K to 61.9 K (+12.95 %) |
Dec 18 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 17.33 | 12,900 | 223,557 | 54,819 | 41.9 K to 54.8 K (+30.77 %) |
Dec 13 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 5,000 | 86,650 | 15,000 | |
Dec 13 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 29.94 | 5,000 | 149,709 | 39,935 | 44.9 K to 39.9 K (-11.13 %) |
Dec 13 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 5,000 | 86,650 | 44,935 | 39.9 K to 44.9 K (+12.52 %) |
Nov 09 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 17.33 | 5,000 | 86,650 | 20,000 | |
Nov 09 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 31.47 | 5,000 | 157,330 | 39,935 | 44.9 K to 39.9 K (-11.13 %) |
Nov 09 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 17.33 | 5,000 | 86,650 | 44,935 | 39.9 K to 44.9 K (+12.52 %) |
Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 100 | 1,733 | 2,169 | |
Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 824 | 14,280 | 2,269 | |
Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 1,497 | 25,943 | 3,093 | |
Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 2,410 | 41,765 | 4,590 | |
Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.51 | 455 | 14,791 | 27,620 | 28.1 K to 27.6 K (-1.62 %) |